Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04144387

Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
395 (actual)
Sponsor
Intergroupe Francophone du Myelome · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.

Detailed description

In 2014, the International Myeloma Working Group (IMWG) proposed a revised classification of multiple myeloma (MM) and smoldering myeloma (SMM). Since the new definition of SMM proposed excludes "ultra-high risk SMM", the evolution profile of SMM will change. Therefore, investigators need to update their knowledge of SMM to optimize the management of patients. This project is expected to describe more precisely the new landscape of SMM. The results will help to establish new recommendations for the standard care of SMM and especially for defining accurate follow-up and risk stratifying.

Conditions

Interventions

TypeNameDescription
PROCEDUREMyelogramTwo additional myelograms will be performed comparing to standard of care.

Timeline

Start date
2020-02-11
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2019-10-30
Last updated
2024-03-06

Locations

90 sites across 3 countries: Belgium, France, Monaco

Source: ClinicalTrials.gov record NCT04144387. Inclusion in this directory is not an endorsement.